Capital Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-32,841
Closed -$2.07M 219
2021
Q1
$2.07M Buy
32,841
+178
+0.5% +$11.1K 0.02% 192
2020
Q4
$2.03M Buy
32,663
+433
+1% +$26.6K 0.02% 191
2020
Q3
$1.94M Buy
32,230
+899
+3% +$54.1K 0.03% 184
2020
Q2
$1.84M Sell
31,331
-4,449
-12% -$266K 0.03% 180
2020
Q1
$1.99M Buy
35,780
+4,562
+15% +$279K 0.03% 168
2019
Q4
$2M Buy
31,218
+20,661
+196% +$1.18M 0.03% 168
2019
Q3
$535K Buy
10,557
+2,958
+39% +$139K 0.01% 215
2019
Q2
$345K Sell
7,599
-381
-5% -$17.7K ﹤0.01% 250
2019
Q1
$381K Buy
7,980
+271
+4% +$13.5K ﹤0.01% 233
2018
Q4
$401K Sell
7,709
-444
-5% -$23.9K 0.01% 232
2018
Q3
$506K Buy
8,153
+399
+5% +$23.7K 0.01% 222
2018
Q2
$429K Sell
7,754
-610
-7% -$32.9K 0.01% 230
2018
Q1
$529K Sell
8,364
-1,000
-11% -$64.3K 0.01% 207
2017
Q4
$574K Buy
9,364
+1,023
+12% +$64K 0.01% 211
2017
Q3
$532K Buy
8,341
+460
+6% +$26.9K 0.01% 205
2017
Q2
$439K Buy
+7,881
New +$429K 0.01% 208

Other funds holding BMY

Capital Bank & Trust's BMY Position: Q2 2021 in Review

Capital Bank & Trust sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 32,841 shares — an estimated $2.07M sold.

Capital Bank & Trust first reported a position in BMY in Q2 2017 and held it in 16 quarters. The position peaked at $2.07M in Q1 2021. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Capital Bank & Trust reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • Capital Bank & Trust sold 32,841 Bristol-Myers Squibb shares in Q2 2021, an estimated $2.07M.
  • Capital Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2017 and held it in 16 quarters.
  • Capital Bank & Trust's Bristol-Myers Squibb position peaked at $2.07M in Q1 2021.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Capital Bank & Trust's 13F filing for Q2 2021, filed 16 Aug 2021.